List of Tables
Table 1. Global Autoimmune and Inflammatory Immunomodulators Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Autoimmune and Inflammatory Immunomodulators Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Autoimmune and Inflammatory Immunomodulators Market Competitive Situation by Manufacturers in 2024
Table 4. Global Autoimmune and Inflammatory Immunomodulators Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Autoimmune and Inflammatory Immunomodulators Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Autoimmune and Inflammatory Immunomodulators Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Autoimmune and Inflammatory Immunomodulators Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Autoimmune and Inflammatory Immunomodulators, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Autoimmune and Inflammatory Immunomodulators, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Autoimmune and Inflammatory Immunomodulators, Product Type & Application
Table 12. Global Key Manufacturers of Autoimmune and Inflammatory Immunomodulators, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Autoimmune and Inflammatory Immunomodulators by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune and Inflammatory Immunomodulators as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Autoimmune and Inflammatory Immunomodulators Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Autoimmune and Inflammatory Immunomodulators Sales by Region (2020-2025) & (K Units)
Table 18. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Region (2020-2025)
Table 19. Global Autoimmune and Inflammatory Immunomodulators Sales by Region (2026-2031) & (K Units)
Table 20. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Region (2026-2031)
Table 21. Global Autoimmune and Inflammatory Immunomodulators Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Region (2020-2025)
Table 23. Global Autoimmune and Inflammatory Immunomodulators Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Region (2026-2031)
Table 25. North America Autoimmune and Inflammatory Immunomodulators Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Autoimmune and Inflammatory Immunomodulators Sales by Country (2020-2025) & (K Units)
Table 27. North America Autoimmune and Inflammatory Immunomodulators Sales by Country (2026-2031) & (K Units)
Table 28. North America Autoimmune and Inflammatory Immunomodulators Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Autoimmune and Inflammatory Immunomodulators Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Autoimmune and Inflammatory Immunomodulators Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Autoimmune and Inflammatory Immunomodulators Sales by Country (2020-2025) & (K Units)
Table 32. Europe Autoimmune and Inflammatory Immunomodulators Sales by Country (2026-2031) & (K Units)
Table 33. Europe Autoimmune and Inflammatory Immunomodulators Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Autoimmune and Inflammatory Immunomodulators Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Autoimmune and Inflammatory Immunomodulators Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Autoimmune and Inflammatory Immunomodulators Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Autoimmune and Inflammatory Immunomodulators Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Autoimmune and Inflammatory Immunomodulators Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Autoimmune and Inflammatory Immunomodulators Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Autoimmune and Inflammatory Immunomodulators Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Autoimmune and Inflammatory Immunomodulators Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Autoimmune and Inflammatory Immunomodulators Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Autoimmune and Inflammatory Immunomodulators Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Autoimmune and Inflammatory Immunomodulators Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Autoimmune and Inflammatory Immunomodulators Sales (K Units) by Type (2020-2025)
Table 51. Global Autoimmune and Inflammatory Immunomodulators Sales (K Units) by Type (2026-2031)
Table 52. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Type (2020-2025)
Table 53. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Type (2026-2031)
Table 54. Global Autoimmune and Inflammatory Immunomodulators Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Autoimmune and Inflammatory Immunomodulators Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Type (2020-2025)
Table 57. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Type (2026-2031)
Table 58. Global Autoimmune and Inflammatory Immunomodulators Price (USD/Unit) by Type (2020-2025)
Table 59. Global Autoimmune and Inflammatory Immunomodulators Price (USD/Unit) by Type (2026-2031)
Table 60. Global Autoimmune and Inflammatory Immunomodulators Sales (K Units) by Application (2020-2025)
Table 61. Global Autoimmune and Inflammatory Immunomodulators Sales (K Units) by Application (2026-2031)
Table 62. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Application (2020-2025)
Table 63. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Application (2026-2031)
Table 64. Global Autoimmune and Inflammatory Immunomodulators Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Autoimmune and Inflammatory Immunomodulators Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Application (2020-2025)
Table 67. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Application (2026-2031)
Table 68. Global Autoimmune and Inflammatory Immunomodulators Price (USD/Unit) by Application (2020-2025)
Table 69. Global Autoimmune and Inflammatory Immunomodulators Price (USD/Unit) by Application (2026-2031)
Table 70. AbbVie Company Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. AbbVie Autoimmune and Inflammatory Immunomodulators Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Johnson & Johnson Company Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Amgen Company Information
Table 81. Amgen Description and Business Overview
Table 82. Amgen Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Amgen Autoimmune and Inflammatory Immunomodulators Product
Table 84. Amgen Recent Developments/Updates
Table 85. F. Hoffmann-La Roche Company Information
Table 86. F. Hoffmann-La Roche Description and Business Overview
Table 87. F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Product
Table 89. F. Hoffmann-La Roche Recent Developments/Updates
Table 90. Pfizer Company Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Pfizer Autoimmune and Inflammatory Immunomodulators Product
Table 94. Pfizer Recent Developments/Updates
Table 95. AstraZeneca Company Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. AstraZeneca Autoimmune and Inflammatory Immunomodulators Product
Table 99. AstraZeneca Recent Developments/Updates
Table 100. Avaxia Biologics Company Information
Table 101. Avaxia Biologics Description and Business Overview
Table 102. Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Product
Table 104. Avaxia Biologics Recent Developments/Updates
Table 105. Biogen Idec Company Information
Table 106. Biogen Idec Description and Business Overview
Table 107. Biogen Idec Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Biogen Idec Autoimmune and Inflammatory Immunomodulators Product
Table 109. Biogen Idec Recent Developments/Updates
Table 110. Bristol-Myers Squibb Company Information
Table 111. Bristol-Myers Squibb Description and Business Overview
Table 112. Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Product
Table 114. Bristol-Myers Squibb Recent Developments/Updates
Table 115. Boehringer Ingelheim Company Information
Table 116. Boehringer Ingelheim Description and Business Overview
Table 117. Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Product
Table 119. Boehringer Ingelheim Recent Developments/Updates
Table 120. Eli Lilly Company Information
Table 121. Eli Lilly Description and Business Overview
Table 122. Eli Lilly Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Eli Lilly Autoimmune and Inflammatory Immunomodulators Product
Table 124. Eli Lilly Recent Developments/Updates
Table 125. Enlivex Therapeutics Company Information
Table 126. Enlivex Therapeutics Description and Business Overview
Table 127. Enlivex Therapeutics Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Enlivex Therapeutics Autoimmune and Inflammatory Immunomodulators Product
Table 129. Enlivex Therapeutics Recent Developments/Updates
Table 130. Gilead Sciences Company Information
Table 131. Gilead Sciences Description and Business Overview
Table 132. Gilead Sciences Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Gilead Sciences Autoimmune and Inflammatory Immunomodulators Product
Table 134. Gilead Sciences Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Autoimmune and Inflammatory Immunomodulators Distributors List
Table 138. Autoimmune and Inflammatory Immunomodulators Customers List
Table 139. Autoimmune and Inflammatory Immunomodulators Market Trends
Table 140. Autoimmune and Inflammatory Immunomodulators Market Drivers
Table 141. Autoimmune and Inflammatory Immunomodulators Market Challenges
Table 142. Autoimmune and Inflammatory Immunomodulators Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Autoimmune and Inflammatory Immunomodulators
Figure 2. Global Autoimmune and Inflammatory Immunomodulators Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Autoimmune and Inflammatory Immunomodulators Market Share by Type: 2024 & 2031
Figure 4. Biologics Product Picture
Figure 5. Small Molecules Product Picture
Figure 6. Global Autoimmune and Inflammatory Immunomodulators Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Autoimmune and Inflammatory Immunomodulators Market Share by Application: 2024 & 2031
Figure 8. Rheumatoid Arthritis
Figure 9. IBD
Figure 10. Global Autoimmune and Inflammatory Immunomodulators Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Autoimmune and Inflammatory Immunomodulators Market Size (2020-2031) & (US$ Million)
Figure 12. Global Autoimmune and Inflammatory Immunomodulators Sales (2020-2031) & (K Units)
Figure 13. Global Autoimmune and Inflammatory Immunomodulators Average Price (USD/Unit) & (2020-2031)
Figure 14. Autoimmune and Inflammatory Immunomodulators Report Years Considered
Figure 15. Autoimmune and Inflammatory Immunomodulators Sales Share by Manufacturers in 2024
Figure 16. Global Autoimmune and Inflammatory Immunomodulators Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Autoimmune and Inflammatory Immunomodulators Players: Market Share by Revenue in Autoimmune and Inflammatory Immunomodulators in 2024
Figure 18. Autoimmune and Inflammatory Immunomodulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Autoimmune and Inflammatory Immunomodulators Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Autoimmune and Inflammatory Immunomodulators Sales Market Share by Country (2020-2031)
Figure 21. North America Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Country (2020-2031)
Figure 22. U.S. Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Autoimmune and Inflammatory Immunomodulators Sales Market Share by Country (2020-2031)
Figure 25. Europe Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Country (2020-2031)
Figure 26. Germany Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Autoimmune and Inflammatory Immunomodulators Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Region (2020-2031)
Figure 33. China Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Taiwan Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Philippines Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Autoimmune and Inflammatory Immunomodulators Sales Market Share by Country (2020-2031)
Figure 44. Latin America Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Autoimmune and Inflammatory Immunomodulators by Type (2020-2031)
Figure 54. Global Revenue Market Share of Autoimmune and Inflammatory Immunomodulators by Type (2020-2031)
Figure 55. Global Autoimmune and Inflammatory Immunomodulators Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Autoimmune and Inflammatory Immunomodulators by Application (2020-2031)
Figure 57. Global Revenue Market Share of Autoimmune and Inflammatory Immunomodulators by Application (2020-2031)
Figure 58. Global Autoimmune and Inflammatory Immunomodulators Price (USD/Unit) by Application (2020-2031)
Figure 59. Autoimmune and Inflammatory Immunomodulators Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
